Galderma Fights Appeal Fee Bid In NYU Oracea Dispute
Galderma Laboratories Inc. on Wednesday hit back at New York University's bid for it to pay attorneys' fees stemming from an appeal over a decision invalidating patents behind rosacea treatment Oracea,...To view the full article, register now.
Already a subscriber? Click here to view full article